A major health problem in various parts of the world and in Egypt is schistosomiasis of the liver and spleen.' The disease is well known for the bleeding tendency that may result from diminished synthesis of coagulation factors, fibrinolytic system activation, and consumption coagulopathy.2`' Acute attacks of haematemesis from ruptured oesophageal varices are often life-threatening and are probably exacerbated by impaired haemostatic and fibrinolytic mechanisms. 5 We studied some variables of the fibrinolytic system, both in compensated and decompensated states of the disease, to clarify the part played by fibrinolytic activity during the acute attacks of haematemesis secondary to ruptured oesophageal varices.
Methods
This study included 72 subjects: 15 
Discussion
This study attempted to shed light on the part played by fibrinolytic mechanisms in causing the haemostatic abnormalities seen in hepatosplenic schistosomiasis. The results obtained showed a progressive decrease in fibrinogen concentration as disease advanced which was more obvious in groups 3 and 4. More than one factor is responsible for the hypofibrinogenaemia occurring in chronic liver disease: decreased hepatic synthesis; increased consumption during intravascular coagulation; destruction by abnormal plasma fibrinolytic activity; and unreplaced loss during massive haemorrhage from oesophageal varices.9 Exchange of plasma fibrinogen into ascitic fluid or increased catabolism will also hasten the rapid disappearance of fibrinogen from plasma.'0 The progressive decrease in plasminogen concentration as disease advanced could be explained by decreased synthesis owing to hepatic fibrosis or increased consumption by enhanced fibrinolytic activity, or both. Fibrin degradation products were increased in patients' sera, being the lowest in group 1 and the highest in group 4. The existence of the progressively increasing concentrations of fibrin degradation products on the one hand, and the progressive decrease of fibrinogen and plasminogen concentrations and platelet count on the other, could be accounted for by the enhanced fibrinolytic activity or disseminated intravascular coagulation, or both, which often accompany hepatic fibrosis in patients with schistosomiasis, especially in the advanced ascitic and haemorrhagic groups. The occurrence of disseminated intravascular coagulation could be attributable to exposure of blood to the expanded collaterals and the distorted splenic circulation in conjunction with impaired hepatic clearing of the procoagulants." Localised intravascular coagulation might also be the outcome of microthrombi present in hepatic venules at the site of schistosomal granulomas, or pressure necrosis affecting the peripheral hepatocytes.'2 The a,-macroglobulin concentration was increased in groups 1-3, reverting to normal in group 4, which differs from that of other acute phase proteins such as haptoglobin, transferrin, or olantitrypsin. These are known to decrease in chronic liver disease due to diminished synthesis by the liver-their main site of synthesis. The significant increase in a2-macroglobulin can thus be attributed to immunomodulatory functions, 13 while its decrease in group 4 might be due to increased consumption in the complexes formed with excess plasmin and thrombin.'4 Antithrombin III concentration progressively decreased as the disease advanced, probably as a result of impaired hepatic synthesis and increased consumption.'5 Clinactivator concentration showed no significant difference between the disease groups and normal controls in any stage of the disease. The data obtained from group 4 during acute attack of haematemesis showed low concentrations of fibrinogen, plasminogen, and a2-macroglobulin, a low platelet count and very high concentration of fibrin degradation products. These data indicate that increased fibrinolysis or disseminated intravascular coagulation, or both, may be present during an acute attack of haematemesis. This suggests that disseminated intravascular coagulation and increased fibrinolysis are important factors that underlie the haemorrhagic diathesis seen in hepatosplenic schistosomiasis.
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